A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

NCT06557265 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Nephritis
Primary Membranous Nephropathy

Interventions

DRUG: NKX019
DRUG: Fludarabine, Cyclophosphamide

Sponsor

Nkarta, Inc.